Lupin acquires brands ONDERO, ONDERO MET brand from Boehringer Ingelheim
Lupin acquires brands ONDERO, ONDERO MET brand from Boehringer Ingelheim
Lupin Limited | 21/08/2023 | By Sudeep Soparkar | 608
Lupins Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Lupin’s Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Lupin Limited | 14/08/2023 | By Sudeep Soparkar | 798
Lupin receives tentative approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets
Lupin Limited | 24/07/2023 | By Sudeep Soparkar | 579
Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP
Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP
Lupin Limited | 18/07/2023 | By Sudeep Soparkar | 571
Lupin receives approval from U.S. FDA for Diazepam Rectal Gel
Global pharma major Lupin Limited (Lupin) today announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has received approval from the United States Food and Drug Administration (U.S. FDA)
Lupin Limited | 02/06/2023 | By Sudeep Soparkar | 711
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy